TRIS PHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at TRIS PHARMA is $78,000, based on 108 certified filings from FY 2020 to FY 2025. This is 35% lower than the national H-1B median salary of $120,000. Compensation at TRIS PHARMA reflects their market positioning, with entry-level roles starting around $61,963 and senior positions reaching $113,318 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at TRIS PHARMA range from $58,739 at the 10th percentile to $113,318 at the 90th percentile, showing a $54,579 spread across experience levels and roles. The 25th percentile is $61,963 and the 75th percentile is $97,739.

Yes, TRIS PHARMA actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 119 H-1B labor condition applications from FY 2020 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 108 certified applications and a 0.8% denial rate, TRIS PHARMA maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), TRIS PHARMA filed 18 H-1B applications, with 18 certified and 0 denied. Over 6 years of data, TRIS PHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

TRIS PHARMA's LCA (Labor Condition Application) denial rate is 0.8%, with 1 out of 119 applications denied across all years. This translates to a 99.2% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating TRIS PHARMA as a potential H-1B sponsor.

This is a good approval rate, comparable to industry averages. TRIS PHARMA demonstrates reliable H-1B sponsorship practices.

TRIS PHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 108 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles TRIS PHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at TRIS PHARMA:

The most frequently sponsored role is Research Scientist II with 17 filings at a median salary of $85,352. This is followed by Research Scientist I (12 filings) and Research Scientist.

TRIS PHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where TRIS PHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top TRIS PHARMA H-1B locations:

The largest H-1B hub for TRIS PHARMA is Monmouth Junction, NJ with 108 filings at a median salary of $78,000.

TRIS PHARMA's median H-1B salary has increased by +57% from FY 2020 ($62,296) to FY 2025 ($97,739). Tracking salary trends over time reveals how TRIS PHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at TRIS PHARMA.

Year-by-year breakdown:

• FY 2021: $76,836 (12 certified)
• FY 2022: $65,000 (12 certified)
• FY 2023: $80,184 (20 certified)
• FY 2024: $85,352 (20 certified)
• FY 2025: $97,739 (18 certified)

This 57% growth reflects strong compensation adjustments at TRIS PHARMA, keeping pace with market demands for H-1B talent.

TRIS PHARMA primarily files H-1B applications at Wage Level I, accounting for 43% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making TRIS PHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

TRIS PHARMA has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

TRIS PHARMA's median H-1B salary of $78,000 is 35% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating TRIS PHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare TRIS PHARMA's offerings with similar companies in your field for a more accurate assessment.

TRIS PHARMA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. TRIS PHARMA files 43% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 108 certified filings, TRIS PHARMA invests significantly in H-1B sponsorship. The company's 0.8% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.